Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

PaperCitations, authors & open-access status

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 669 citations, 2018 year and bronze oa status.

669
Citations
2018
Year
bronze
OA Status

Related on ScholarIQ

Jaskaran Singh
Author
Rosanne Lane
Author
Wayne C. Drevets
Author
Treatment of Major Depression
Topic
Treatment of Major Depression
Topic
Suicide and Self-Harm Studies
Topic
470M+ articles · free account